Cargando...
Could valproic acid be an effective anticancer agent? The evidence so far
Valproic acid is an inhibitor of class I histone deacetylases. Epigenetic therapies in cancer have been focus of a keen interest and HDAC inhibitors in particular have been approved for certain types of hematologic malignancies. Valproic acid is an attractive candidate for cancer therapy due to its...
Guardado en:
| Publicado en: | Expert Rev Anticancer Ther |
|---|---|
| Autores principales: | , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2014
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4579528/ https://ncbi.nlm.nih.gov/pubmed/25017212 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1586/14737140.2014.940329 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|